Circulating adipocytokines in morbid obese patients, relation with cardiovascular risk factors and anthropometric parameters

Nutricion Hospitalaria

Volumn 26, Issue 1, 2011, Pages 91-96

  De Luis, D A ^a   Gonzalez Sagrado M ^a   Conde, R ^a   Aller, R ^a   Izaola, O ^a   Castro, M J ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Adypocitokines; Anthropometry; Cardiovascular risk factors; Morbid obesity

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; LIPID;

ANTHROPOMETRY; ARTICLE; BLOOD; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CALORIMETRY; CARDIOVASCULAR DISEASE; DIET; INSULIN RESISTANCE; MORBID OBESITY; PHYSIOLOGY; RISK FACTOR; WAIST CIRCUMFERENCE;

ADIPOKINES; ANTHROPOMETRY; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CALORIMETRY, INDIRECT; CARDIOVASCULAR DISEASES; DIET; INSULIN RESISTANCE; LIPIDS; OBESITY, MORBID; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 79952978198     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2011.26.1.4685     Document Type: Article

References (29)

1. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-919.
2. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chemistry 2004; 50: 1511-1525. (Pubitemid 39121218)
3. Matsuda M, Shimomura I, Sata M. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol CHem 2002; 277: 37487-37491.
4. Kumada M, Kihara S, Sumitsuji S. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-9. (Pubitemid 36091630)
5. Shimomoura I, Hammer RE, Ikemoto S. Leptin reverses insulin resitance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999; 401: 73-76.
6. Steppan CM, Bailey ST, Bhat S. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312. (Pubitemid 32151228)
7. Matsuzawa Y. Adipocytokines: Emerging therapeutic targets. Current Atherosclerosis Reports 2005; 7: 58-62. (Pubitemid 40394231)
8. DA de luis, M Gonzalez Sagrado, R Conde, R Aller, O Izaola. Circulating adipocytokines in obese non diabetic patients, relation with cardiovascular risk factors, anthropometry and resting energy expenditure. Ann Nutr Metab 2007; 51: 374-378.
9. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher Df. Homesotasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-414.
10. Feurer ID, Mullen JL. Bedside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry. Nutr Clin Pract 1986; 1: 43-49.
11. a.
12. Mataix J, Mañas M. Tablas de composición de alimentos españoles. Ed: University of Granada, 2003.
13. Speakman JR, Stubbs RJ, Mercer JG. Does body mass play a role in the regulation of food intake? Proc Nutr Soc 2002; 61: 473-487. (Pubitemid 36069936)
14. Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW. Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord 2003; 27: 875-888. (Pubitemid 36918608)
15. Margetic S, Gazzola C, Pegg GG. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002; 26: 1407-1433. (Pubitemid 36007818)
16. Pagano C, Marin O, Calcagno A, Schiappelli P, Pilon C, Milan C. Increased serum resistin in adults with Prader-Willi syndrome is related to obesity and not to insulin resistance. J Clin Endocrinol Metab 2005; 90: 4335-4340. (Pubitemid 41058216)
17. Bootnes A, Kratzsch J, Seidel B. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin endocrinol Metab 2004; 89: 4053-4061. (Pubitemid 39071513)
18. Matsuzawa Y, Funahashi T, Kihara S. Adiponectin and metabolic syndrome. Atheroscler Thromn Vasc Biol 2004; 24: 29-33. (Pubitemid 38082408)
19. Mantzmoros CS, Manson JE, Meigs J, Hu FB. Circulating adiponectin levels are associated with better glycaemic control, more favourable lipid profile and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 2005; 90: 4542-4548. (Pubitemid 41159340)
20. Bruun JM, Verdich C, Toubro S, Astrup A, Richelsen B. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and TNF alpha. Effect of weight loss in obese patients. Eur J Endocrinol 2003; 148: 535-542. (Pubitemid 36622161)
21. Tschop M, Smiley DL; Heiman ML. Ghrelin induced adiposity in rodents. Nature 2000; 407: 908-913.
22. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-2282. (Pubitemid 38535056)
23. Fantuzzi G. Adipose tissue, adipokines and inflammation. J Allergy Clin Immunol 2005; 115: 911-920.
24. Hotamisligil GS, Murray DL, Choy LN, Spiegeman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994; 91: 4854-5858.
25. Abdella NA, Mojiminiyi OA, Moussa MA, Zaki M, Al Mohammedi H. Plasma leptin concentration in patients with type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance. Diabet Med 2005; 22: 278-285. (Pubitemid 40313854)
26. Yannakoulia M, Yiannakouris N, Bluher S, Matalas AL, Klimis-Zacas D, Mantzoros CS. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin , and resistin concentrations in healthy humans. J Clin Endocrinol Metab 2003; 88: 1730-1736. (Pubitemid 36623396)
27. De Luis DA, Aller R, González Sagrado M, Izaola O, Conde R. The effects of a low fat versus a low carbohydrate diet on adipocytokines in obese adults. Hormone Research 2007; 67: 296-300. (Pubitemid 46701495)
28. De Luis DA, Aller R, Izaola O, González Sagrado, Conde R, Pérez Castrillon JL. Effects of lifestyle modification on adipocytokine levels in obese patients. Eur Rev Med Pharmacol Sci 2008; 12: 33-39. (Pubitemid 351425353)
29. De la Torre NG, Rubio MA, Bordiu E, Cabrerizo L Aparicio E Hernández E. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines and insulin. J Clin Endocrinol Metab 2008; Epub ahead of print.